News & Media

Research News

A novel inhibitor as therapeutic potential against pancreatic and hepatocellular cancers

27 January 2022

This study reports a novel inhibitor oxide (MPO) which promotes inhibition of growth in pancreatic and hepatocellular ca...

Read More →

Research News

Pseudogene demethylation activates oncogenes in Hepatocellular carcinoma

21 December 2021

Hepatitis B virus (HBV) infection is one of the main causes of Hepatocellular carcinoma (HCC) which is one of leading ca...

Read More →

Research News

Fatty acid oxidation inhibits breast cancer cells in animal models

21 December 2021

Fatty acids oxidation (FAO) confers Epithelial-to-mesenchymal transition causing enhanced tumorigenicity and drug resist...

Read More →

Research News

Liver transplantation for metastatic tumours

21 December 2021

More than 50% of colorectal cancer patients develop metastases to the liver. Liver resection is considered the only trea...

Read More →

Research News

Vaccine therapy for nasopharyngeal carcinoma

21 December 2021

Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC) and provides a potential target for dendritic...

Read More →

Media

A/Prof Too’s Interview after winning the President’s Technology Award 2021

15 December 2021

  Hear A/Prof Too’s thoughts about his win!

Read More →

News

32 NUS scientists among the world’s most highly cited researchers

16 November 2021

Thirty-two NUS researchers have been placed among some of the world’s most highly cited researchers, according to the ...

Read More →

Research News

NUS researchers discover possible new treatment option for aggressive forms of breast cancer

3 November 2021

Women diagnosed with the biologically aggressive triple-negative (TNBC) and endocrine-refractory subtypes of breast canc...

Read More →